Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
Tyrosine kinase inhibitors
Diarrhea
Treatment
Social sciences (General)
H1-99
0301 basic medicine
Q1-390
03 medical and health sciences
Science (General)
Mechanism
Review Article
DOI:
10.1016/j.heliyon.2024.e27531
Publication Date:
2024-03-06T03:53:44Z
AUTHORS (7)
ABSTRACT
Tyrosine kinase inhibitors (TKIs) have become first-line drugs for cancer treatment. However, their clinical use is seriously hindered since many patients experience diarrhea after receiving TKIs. The mechanisms of TKI-associated remain unclear. Most existing therapies are symptomatic treatments based on and effects unsatisfactory. Therefore, clarification the underlying critical to develop effective anti-diarrhea drugs. This article summarizes several potential reviews current treatment progress.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (86)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....